A
Annika Janson
Researcher at Karolinska Institutet
Publications - 31
Citations - 836
Annika Janson is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Medicine & Obesity. The author has an hindex of 10, co-authored 26 publications receiving 686 citations. Previous affiliations of Annika Janson include University of London & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Prevalence of obesity in Sweden.
TL;DR: The development during the last decades is alarming in adults, adolescents and children alike, and most reports on childhood overweight stem from the larger metropolitan areas, and hence may be underestimates because of the urban–rural influence on obesity‐status.
Journal ArticleDOI
Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: Randomised cross-over trial in Tanzania
Marycelina Mubi,Annika Janson,Marian Warsame,Andreas Mårtensson,Karin Källander,Max Petzold,Billy Ngasala,Billy Ngasala,Gloria Maganga,Lars L. Gustafsson,Amos Massele,Göran Tomson,Zul Premji,Anders Björkman +13 more
TL;DR: RDTs in the hands of CHWs may safely improve early and well-targeted ACT treatment in malaria patients at community level in Africa and support the safety of withholding ACT to RDT negative patients.
Journal ArticleDOI
Evidence for the presence of functional thyrotropin receptor in cardiac muscle
Viktor Drvota,Annika Janson,C. Norman,Christer Sylvén,J. Haggblad,M. Bronnegard,Claude Marcus +6 more
TL;DR: Functional TSHR is present in cardiomyocytes according to reverse transcriptase polymerase chain reactions in human heart and Northern blot on extracted RNA showed a RNA species of 4.4 kb.
Journal ArticleDOI
Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes.
TL;DR: The clinically and statistically significant weight reduction caused by sibutramine in this short-term study indicates that treatment of hypothalamic and syndromal obesity with this drug may be beneficial.
Journal ArticleDOI
Clinical and immunological characteristics of Autoimmune Addison's disease : a nationwide Swedish multicenter study
Frida Dalin,Gabriel Nordling Eriksson,Per Dahlqvist,Åsa Hallgren,Jeanette Wahlberg,Olov Ekwall,Stefan Söderberg,Johan Rönnelid,Per Olcén,Ola Winqvist,Sergiu-Bogdan Catrina,Berit Kriström,Maria Laudius,Magnus Isaksson,Maria Halldin Stenlid,Jan Gustafsson,Gennet Gebre-Medhin,Sigridur Bjornsdottir,Annika Janson,Anna Karin Åkerman,Jan Åman,Karel Duchén,Ragnhildur Bergthorsdottir,Gudmundur Johannsson,Emma Lindskog,Mona Landin-Olsson,Maria Elfving,Erik Waldenström,Anna Lena Hulting,Olle Kämpe,Sophie Bensing +30 more
TL;DR: Careful monitoring of AAD patients is warranted to detect associated autoimmune diseases, and high glucocorticoid replacement doses could be a risk factor for hypertension.